EMA Fast-Tracks Approval for Adapted COVID-19 Variant Vaccines In an agile response to the rapidly mutating SARS-CoV-2 virus, the European Medicines Agency (EMA) has set forth new guidance to expedite the regulatory approval of COVID-19 vaccines modified to combat emerging variants. This move
Solvias' announcement of opening a new biotech facility in Research Triangle Park, North Carolina, has sparked excitement and anticipation within the Raleigh-Durham area. The region, already renowned for its concentration of tech and biotech firms, is poised to add another jewel to its crown
The biotech industry is poised for transformative growth, fueled by scientific breakthroughs and the application of cutting-edge technologies. In this nexus of innovation, 21st.BIO stands out with its recent announcement of a new pilot plant in the heart of Europe's biotech landscape. This
ChargePoint Technology is taking a significant leap to scale up its manufacturing capabilities amid surging demand for single-use disposable systems in the pharmaceutical sector. By pouring investment into a state-of-the-art facility in Speke, Liverpool, the company aims to strengthen its position
The Inflation Reduction Act (IRA) marks a significant milestone in U.S. healthcare reform, particularly for those covered by Medicare. This comprehensive legislation introduces an array of policy changes poised to transform numerous sectors within the healthcare industry. One of the most crucial
In a groundbreaking initiative, Moderna has joined forces with AI powerhouse OpenAI to revolutionize vaccine development through artificial intelligence. This move signifies a fusion of Moderna's medical prowess with OpenAI's advanced AI technology. Together, they seek to transform the
